KHATTAR JACK A. (President, CEO) exercised options at SUPERNUS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/14/2026ACC: 0001539937-26-000012
DirectorOfficer· President, CEO
Since Feb 2026
-12.64K
Net shares
Net seller
$588.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
29.85K acquired · 42.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+29.85K
Price / share
—
Trade value
—
% of position
2.4%
8/12/2026
1.24M→1.27M
Common Stock
Direct
Shares
−12.64K
Price / share
$46.57
Trade value
$588.74K
% of position
1.0%
8/12/2026
1.27M→1.26M
Total
Net shares
+17.21K
Net value
-$588.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2026 | M · Option Exercise | +29.85K | — | — | 2.4% | 1.24M | 1.27M |
| Common Stock Direct | 8/12/2026 | F · Tax Withholding | −12.64K | $46.57 | $588.74K | 1.0% | 1.27M | 1.26M |
| Total | +17.21K | -$588.74K | ||||||
Derivative Transactions1
Performance Share Unit
Direct
Converts to
Common Stock
29.85K shares
Shares
−29.85K
Strike price
0
Held after
0.00
Exercisable
—
8/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Share Unit Direct | Common Stock29.85K shares | 8/12/2026 | M · Option Exercise | −29.85K | 0 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned958.10K
Total
958.10K indirect958.10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 958.10K | Indirect |
| Total | 958.10K | 958.10K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported